Patents by Inventor Rola Saouaf

Rola Saouaf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Detectably labeled porphyrin compound for identifying the sentinel lymph node
    Patent number: 7198775
    Abstract: A detectably labeled porphyrin compound for identifying a sentinel lymph node in patients, particularly those with cancer. A method of identifying a sentinel lymph node, comprising the steps of: injecting the detectably labeled porphyrin compound into a tumor, wherein the porphyrin compound is detectably labeled with a radiolabel which is a ?-emitting radioactive metal; and detecting radioactive emission or a color so as to detect and thereby identify the sentinel lymph node. A method of identifying a sentinel lymph node, comprising the steps of injecting the detectably labeled porphyrin compound into tissue surrounding a tumor, wherein the porphyrin compound is detectably labeled with a non-radioactive metal; and taking a series of magnetic resonance images to identify the sentinel lymph node by viewing the images showing the injected detectably labeled porphyrin compound.
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: April 3, 2007
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Mahmoud El-Tamer, Rashid Fawaz, Theodore Wang, Ted Chaglassian, Rola Saouaf
  • Detectably labeled porphyrin compound for identifying the sentinel lymph node
    Publication number: 20020192158
    Abstract: A detectably labeled porphyrin compound for identifying a sentinel lymph node in patients, particularly those with cancer. A method of identifying a sentinel lymph node, comprising the steps of: injecting the detectably labeled porphyrin compound into a tumor, wherein the porphyrin compound is detectably labeled with a radiolabel which is a &ggr;-emitting radioactive metal; and detecting radioactive emission or a color so as to detect and thereby identify the sentinel lymph node. A method of identifying a sentinel lymph node, comprising the steps of injecting the detectably labeled porphyrin compound into tissue surrounding a tumor, wherein the porphyrin compound is detectably labeled with a non-radioactive metal; and taking a series of magnetic resonance images to identify the sentinel lymph node by viewing the images showing the injected detectably labeled porphyrin compound.
    Type: Application
    Filed: July 19, 2002
    Publication date: December 19, 2002
    Applicant: The Trustees of Columbia University in the City of New York.
    Inventors: Mahmoud El-Tamer, Rashid Fawaz, Theodore Wang, Ted Chaglassian, Rola Saouaf
  • Detectably labeled porphyrin compound for identifying the sentinel lymph node
    Patent number: 6458336
    Abstract: A detectably labeled porphyrin compound for identifying a sentinel lymph node in patients, particularly those with cancer. A method of identifying a sentinel lymph node, comprising the steps of: injecting the detectably labeled porphyrin compound into a tumor, wherein the porphyrin compound is detectably labeled with a radiolabel which is a &ggr;-emitting radioactive metal; and detecting radioactive emission or a color so as to detect and thereby identify the sentinel lymph node. A method of identifying a sentinel lymph node, comprising the steps of injecting the detectably labeled porphyrin compound into tissue surrounding a tumor, wherein the porphyrin compound is detectably labeled with a non-radioactive metal; and taking a series of magnetic resonance images to identify the sentinel lymph node by viewing the images showing the injected detectably labeled porphyrin compound.
    Type: Grant
    Filed: May 30, 2000
    Date of Patent: October 1, 2002
    Assignee: The Trustees of Columbia University in the City of New York
    Inventors: Mahmoud El-Tamer, Rashid Fawaz, Theodore Wang, Ted Chaglassian, Rola Saouaf